These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9401351)

  • 1. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Mar; 59(2):205-32. PubMed ID: 9116600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy.
    Jackson TL; Byrne HM
    Math Biosci; 2000 Mar; 164(1):17-38. PubMed ID: 10704636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for metastases formation.
    Markovitch S
    Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model of the development of drug resistance to cancer chemotherapy.
    Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative model for multiple levels of drug resistance in clinical tumors.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1983 Oct; 67(10):923-31. PubMed ID: 6627236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of cell proliferation.
    Moxnes JF; Haux J; Hausken K
    Med Hypotheses; 2004; 62(4):556-63. PubMed ID: 15050107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bilinear control model for tumor growth and chemotherapy.
    Vaidya VG; Alexandro FJ; Vaidya PG
    Int J Biomed Comput; 1985 Sep; 17(2):145-54. PubMed ID: 4055120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
    Murray JM
    Math Biosci; 1994 Oct; 123(2):183-213. PubMed ID: 7827419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).
    Skipper HE
    Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth of necrotic tumors in the presence and absence of inhibitors.
    Byrne HM; Chaplin MA
    Math Biosci; 1996 Jul; 135(2):187-216. PubMed ID: 8768220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical approaches to optimization of cancer chemotherapy.
    Zietz S; Nicolini C
    Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827
    [No Abstract]   [Full Text] [Related]  

  • 19. A stochastic model of the acquisition of drug resistance during antineoplastic chemotherapy.
    Abundo M; Rossi C; Benassi M; Gentile FP; Mauro F
    Health Phys; 1989; 57 Suppl 1():349-54. PubMed ID: 2606692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival.
    Cook AB; Ziazadeh DR; Lu J; Jackson TL
    Math Biosci Eng; 2015 Dec; 12(6):1219-35. PubMed ID: 26775858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.